PDB Short entry for 2YY1 HEADER SUGAR BINDING PROTEIN 27-APR-07 2YY1 TITLE CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN GALECTIN-9 CONTAINING TITLE 2 L-ACETYLLACTOSAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, UNP RESIDUES 1-147; COMPND 5 SYNONYM: HOM-HD-21, ECALECTIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CELL-FREE PROTEIN SYNTHESIS; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PK060220-05 KEYWDS SUGER BINDING, GALECTIN, HUMAN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL KEYWDS 2 PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN KEYWDS 3 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SUGAR BINDING KEYWDS 4 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.KISHISHITA,A.NISHINO,K.MURAYAMA,T.TERADA,M.SHIROUZU,S.YOKOYAMA, AUTHOR 2 RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 09-SEP-20 2YY1 1 TITLE JRNL HETSYN REVDAT 3 29-JUL-20 2YY1 1 COMPND REMARK SEQADV HET REVDAT 3 2 1 HETNAM FORMUL LINK SITE REVDAT 3 3 1 ATOM REVDAT 2 24-FEB-09 2YY1 1 VERSN REVDAT 1 29-APR-08 2YY1 0 JRNL AUTH S.KISHISHITA,A.NISHINO,K.MURAYAMA,T.TERADA,M.SHIROUZU, JRNL AUTH 2 S.YOKOYAMA JRNL TITL CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN GALECTIN-9 JRNL TITL 2 CONTAINING L-ACETYLLACTOSAMINE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 120533.100 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 13808 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 686 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1818 REMARK 3 BIN R VALUE (WORKING SET) : 0.2070 REMARK 3 BIN FREE R VALUE : 0.2410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1105 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : 1.09000 REMARK 3 B33 (A**2) : -2.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 28.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.310 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.980 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 62.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LACTO.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : LACTO.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED FOR REMARK 3 PHASING. REMARK 4 REMARK 4 2YY1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000027277. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15074 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 12.89 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 46.3176 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.19000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.30 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM ACETATE TRIHYDRATE, 0.1M REMARK 280 SODIUM CACODYLATE, 30% PEG 8000, 30MM L-ACETYLLACTOSAMINE, PH REMARK 280 6.9, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.80450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 23.70350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.40225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 23.70350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 91.20675 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 23.70350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.40225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 23.70350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 91.20675 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 60.80450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS STRUCTURE INDICATES MONOMER STRUCTURE IN THIS CRYSTAL REMARK 300 PACKING. BUT, THERE IS NO EXPERIMENTAL EVIDENCE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 60.80450 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 GLY A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 GLY A 7 REMARK 465 MET A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 SER A 13 REMARK 465 SER A 155 REMARK 465 GLY A 156 REMARK 465 PRO A 157 REMARK 465 SER A 158 REMARK 465 SER A 159 REMARK 465 GLY A 160 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 47 5.04 98.18 REMARK 500 SER A 48 -100.90 -94.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSS001002697.1 RELATED DB: TARGETDB DBREF 2YY1 A 8 154 UNP O00182 LEG9_HUMAN 1 147 SEQADV 2YY1 GLY A 1 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 2 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 3 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 4 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 5 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 6 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 7 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 155 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 156 UNP O00182 EXPRESSION TAG SEQADV 2YY1 PRO A 157 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 158 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 159 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 160 UNP O00182 EXPRESSION TAG SEQRES 1 A 160 GLY SER SER GLY SER SER GLY MET ALA PHE SER GLY SER SEQRES 2 A 160 GLN ALA PRO TYR LEU SER PRO ALA VAL PRO PHE SER GLY SEQRES 3 A 160 THR ILE GLN GLY GLY LEU GLN ASP GLY LEU GLN ILE THR SEQRES 4 A 160 VAL ASN GLY THR VAL LEU SER SER SER GLY THR ARG PHE SEQRES 5 A 160 ALA VAL ASN PHE GLN THR GLY PHE SER GLY ASN ASP ILE SEQRES 6 A 160 ALA PHE HIS PHE ASN PRO ARG PHE GLU ASP GLY GLY TYR SEQRES 7 A 160 VAL VAL CYS ASN THR ARG GLN ASN GLY SER TRP GLY PRO SEQRES 8 A 160 GLU GLU ARG LYS THR HIS MET PRO PHE GLN LYS GLY MET SEQRES 9 A 160 PRO PHE ASP LEU CYS PHE LEU VAL GLN SER SER ASP PHE SEQRES 10 A 160 LYS VAL MET VAL ASN GLY ILE LEU PHE VAL GLN TYR PHE SEQRES 11 A 160 HIS ARG VAL PRO PHE HIS ARG VAL ASP THR ILE SER VAL SEQRES 12 A 160 ASN GLY SER VAL GLN LEU SER TYR ILE SER PHE SER GLY SEQRES 13 A 160 PRO SER SER GLY HET NDG B 1 15 HET GAL B 2 11 HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE FORMUL 2 NDG C8 H15 N O6 FORMUL 2 GAL C6 H12 O6 FORMUL 3 HOH *63(H2 O) HELIX 1 1 PRO A 134 VAL A 138 5 5 SHEET 1 A 6 TYR A 17 LEU A 18 0 SHEET 2 A 6 VAL A 147 SER A 153 -1 O ILE A 152 N TYR A 17 SHEET 3 A 6 GLN A 37 VAL A 44 -1 N ASN A 41 O SER A 150 SHEET 4 A 6 PRO A 105 VAL A 112 -1 O PHE A 110 N ILE A 38 SHEET 5 A 6 ASP A 116 VAL A 121 -1 O MET A 120 N CYS A 109 SHEET 6 A 6 ILE A 124 PHE A 130 -1 O PHE A 126 N VAL A 119 SHEET 1 B 6 PHE A 24 THR A 27 0 SHEET 2 B 6 THR A 140 GLY A 145 -1 O VAL A 143 N PHE A 24 SHEET 3 B 6 PHE A 52 GLN A 57 -1 N ASN A 55 O SER A 142 SHEET 4 B 6 ILE A 65 ARG A 72 -1 O PHE A 69 N VAL A 54 SHEET 5 B 6 TYR A 78 GLN A 85 -1 O VAL A 80 N ASN A 70 SHEET 6 B 6 SER A 88 TRP A 89 -1 O SER A 88 N GLN A 85 SHEET 1 C 6 PHE A 24 THR A 27 0 SHEET 2 C 6 THR A 140 GLY A 145 -1 O VAL A 143 N PHE A 24 SHEET 3 C 6 PHE A 52 GLN A 57 -1 N ASN A 55 O SER A 142 SHEET 4 C 6 ILE A 65 ARG A 72 -1 O PHE A 69 N VAL A 54 SHEET 5 C 6 TYR A 78 GLN A 85 -1 O VAL A 80 N ASN A 70 SHEET 6 C 6 GLU A 93 LYS A 95 -1 O LYS A 95 N VAL A 79 LINK O4 NDG B 1 C1 GAL B 2 1555 1555 1.43 CISPEP 1 VAL A 22 PRO A 23 0 0.11 CRYST1 47.407 47.407 121.609 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021094 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021094 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008223 0.00000